- Location
Treprostinil
"-
United Therapeutics Obtained an Approval From FDA for Orenitram Extended-Release Tablets
Dec 24, 2013US-based biotechnology company United Therapeutics has obtained an approval from the US Food and Drug Administration (FDA) for the Orenitram (treprostinil) extended-release tablets, indicted for the treatment of pulmonary arterial ...
Tags: Extended-Release Tablets, Medicine
-
United Therapeutics Has Received Complete Response Letter (CRL) From The FDA
Oct 26, 2012United Therapeutics has received complete response letter (CRL) from the FDA for an oral formulation of Remodulin (treprostinil). Treprostinil is indicated for pulmonary arterial hypertension (PAH) that is at present available in ...
Tags: Medicine, Treprostinil
Related Products
-
Twochem Lab Supply Raw Materials Pharmaceutical Intermediates Powder Treprostinil CAS 81846-19-7 API with 99% Pruity
-
CAS 289480-64-4 Remodulin / Treprostinil Sodium Pharmaceutical Raw Material
-
CAS 81846-19-7 Remodulin Pharmaceutical Raw Materials
-
Treprostinil CAS No. 81846-19-7
-
Treprostinil Diolamine CAS No. 830354-48-8
-
Treprostinil Sodium CAS No. 289480-64-4
